RobertTWechslerMD, PhD, FAES, FAAN

Neurology • Boise, ID

Epilepsy, Neurophysiology

Physician

Join to view full profile

Dr. Wechsler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Wechsler's full profile

Already have an account?

Office
1499 West Hays St.
Boise, ID 83702
Phone+1 208-275-8585

Fax+1 208-275-8586
Is this information wrong?

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Epilepsy, 2003 - 2005
Barrow Neurological Institute at St Joseph's Hospital and Medical CenterResidency, Neurology, 2000 - 2003
Creighton University School of Medicine (Phoenix)Internship, Internal Medicine, 1999 - 2000
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1999
Rosalind Franklin/Finch U/Chi Med SchPhD, Parkinson's Disease, 1994 - 1998

Certifications & Licensure

CA State Medical License 2003 - Present
ID State Medical License 2005 - 2024
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Clinical Neurophysiology
American Board of Psychiatry and Neurology Epilepsy

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013

Clinical Trials

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures Start of enrollment: 2007 Aug 01
Completed
Phase 3
Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures Start of enrollment: 2008 Feb 01
Completed
Phase 3
To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures Start of enrollment: 2008 May 01
Completed
Phase 3
Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures Start of enrollment: 2008 Oct 01
Completed
Phase 3
An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam Start of enrollment: 2008 Nov 01
Completed
Phase 3
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs Start of enrollment: 2009 Apr 01
Completed
Phase 3
Eslicarbazepine Acetate Monotherapy Long Term Study Start of enrollment: 2009 Aug 01
Completed
Phase 3
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures Start of enrollment: 2008 Dec 02
Completed
Phase 3
Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy Start of enrollment: 2010 May 01
Completed
Phase 2
Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures Start of enrollment: 2010 Dec 01
Completed
Phase 3
A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®) Start of enrollment: 2010 Dec 01
Completed
Phase 4
Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy Start of enrollment: 2011 May 11
Completed
Phase 3
Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters Start of enrollment: 2011 Jun 01
Terminated
Phase 3
A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures Start of enrollment: 2011 Sep 01
Completed
Phase 3
A Study to Evaluate the Efficacy and Safety of VX-765 in Subjects With Treatment-Resistant Partial Epilepsy Start of enrollment: 2011 Dec 01
Terminated
Phase 2
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters Start of enrollment: 2012 Jul 01
Terminated
Phase 3
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures Start of enrollment: 2013 Jul 31
Completed
Phase 2
An Extended Access Program for Perampanel
No longer available
Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension Start of enrollment: 2013 Oct 01
Completed
Phase 3
Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults Start of enrollment: 2015 Jun 08
Completed
Phase 3
An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes Start of enrollment: 2015 Jun 11
Completed
Phase 3
An Extended Access Program (EAP) for Perampanel
Available
Staccato Alprazolam and Photoparoxysmal Response Start of enrollment: 2015 Jan 01
Completed
Phase 2
A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications Start of enrollment: 2015 Apr 01
Completed
Phase 3
Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures Start of enrollment: 2016 Aug 03
Completed
Phase 3
Cannabidiol for Pediatric Epilepsy (Compassionate Use)
No longer available
PF-06372865 in Subjects With Photosensitive Epilepsy Start of enrollment: 2015 Dec 16
Completed
Phase 2
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome Start of enrollment: 2016 Dec 13
Terminated
Phase 3
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures Start of enrollment: 2016 Nov 16
Completed
Phase 3
A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures Start of enrollment: 2017 Jul 07
Completed
Phase 4
Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy Start of enrollment: 2017 Apr 07
Completed
A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization Start of enrollment: 2017 Aug 05
Enrolling by invitation
Phase 3
Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy Start of enrollment: 2021 Aug 31
Active, not recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

2 citations
Sustainability of seizure reduction and seizure control with adjunctive cenobamate: Post hoc analysis of a phase 3, open-label study.
David G Vossler, William E Rosenfeld, Sean Stern, Clarence T Wade, Louis Ferrari, Wesley T Kerr, Robert Wechsler> ;Epilepsia. 2023 Oct 1
6 citations
Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: Four-year results from the expanded access program.
Jerzy P Szaflarski, Orrin Devinsky, Merrick Lopez, Yong D Park, Pilar Pichon Zentil, Anup D Patel, Elizabeth A Thiele, Robert T Wechsler, Daniel Checketts, Farhad Sahe...> ;Epilepsia. 2023 Mar 1
15 citations
Perampanel monotherapy for the treatment of epilepsy: Clinical trial and real-world evidence.
Takamichi Yamamoto, Antonio Gil-Nagel, James W Wheless, Ji Hyun Kim, Robert T Wechsler> ;Epilepsy & Behavior. 2022 Nov 1
12 citations
PROVE: Retrospective, non-interventional, Phase IV study of perampanel in real-world clinical care of patients with epilepsy.
Robert T Wechsler, James Wheless, Muhammad Zafar, Graham R Huesmann, Marcelo Lancman, Eric Segal, Michael Chez, Sami Aboumatar, Anna Patten, Alejandro Salah, Manoj Mal...> ;Epilepsia Open. 2022 Jun 1
5 citations
Long-term open-label perampanel: Generalized tonic-clonic seizures in idiopathic generalized epilepsy.
Jacqueline A French, Robert T Wechsler, Eugen Trinka, Christian Brandt, Terence J O'Brien, Anna Patten, Alejandro Salah, Manoj Malhotra> ;Epilepsia Open. 2022 Sep 1
23 citations
Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant an...
William E. Rosenfeld, Bassel Abou-Khalil, Sami Aboumatar, Perminder Bhatia, Victor Biton, Gregory L. Krauss, Michael R. Sperling, David G. Vossler, Pavel Klein, Robert...> ;Epilepsia. 2021 Oct 11
22 citations
Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label study.
Michael R. Sperling, Bassel Abou-Khalil, Sami Aboumatar, Perminder Bhatia, Victor Biton, Pavel Klein, Gregory L. Krauss, David G. Vossler, Robert T. Wechsler, Louis Fe...> ;Epilepsia. 2021 Oct 11
1 citations
A multivariable prediction model of a major treatment response for focal-onset seizures: A post-hoc analysis of Phase III trials of perampanel.
Gregory L. Krauss, Elinor Ben-Menachem, Robert T. Wechsler, Anna Patten, Betsy Williams, Antonio Laurenza, Manoj Malhotra> ;Epilepsy Research. 2021 Aug 1
7 citations
Perampanel in real-world clinical care of patients with epilepsy: Interim analysis of a phase IV study.
James W. Wheless, Robert T. Wechsler, Marcelo Lancman, Sami Aboumatar, Anna Patten, Manoj Malhotra> ;Epilepsia Open. 2021 Mar 1
11 citations
Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies.
Ivan Rektor, Gregory L. Krauss, Yushi Inoue, Sunao Kaneko, Betsy Williams, Anna Patten, Manoj Malhotra, Antonio Laurenza, Robert T. Wechsler> ;Epilepsia. 2020 Jul 1
16 citations
Adjunctive perampanel and myoclonic and absence seizures: Post hoc analysis of data from study 332 in patients with idiopathic generalized epilepsy.
Christian Brandt, Robert T. Wechsler, Terence J. O'Brien, Anna Patten, Manoj Malhotra, Leock Y. Ngo, Bernhard J. Steinhoff> ;Seizure. 2020 Aug 1
81 citations
Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study.
Michael R. Sperling, Pavel Klein, Sami Aboumatar, Michael A. Gelfand, Jonathan J. Halford, Gregory L. Krauss, William E. Rosenfeld, David G. Vossler, Robert T. Wechsle...> ;Epilepsia. 2020 Jun 1
1 citations
Have new antiseizure medications improved clinical care over the past 30 years
Jacqueline A. French, Robert T. Wechsler> ;The Lancet. Neurology. 2020 Feb 25
32 citations
Inhaled alprazolam rapidly suppresses epileptic activity in photosensitive participants.
Jacqueline A. French, Robert T. Wechsler, Michael A. Gelfand, John R. Pollard, Blanca Vazquez, Daniel Friedman, Lily Gong, Edwin S. Kamemoto, Jouko I. T. Isojärvi, Jam...> ;Epilepsia. 2019 Aug 1
7 citations
Serum sodium levels and related treatment-emergent adverse events during eslicarbazepine acetate use in adults with epilepsy.
Robert T. Wechsler, Rodney A. Radtke, Michael C. Smith, David G. Vossler, Laura Strom, Eugen Trinka, Hailong Cheng, Todd Grinnell, David Blum, Mariana Vieira, Joana Mo...> ;Epilepsia. 2019 Jul 1
15 citations
Photosensitive epilepsy: Robust clinical efficacy of a selective GABA potentiator.
Rachel Gurrell, Donal Gorman, Mark Whitlock, Adam Ogden, David S. Reynolds, Bree DiVentura, Bassel Abou-Khalil, Michael A. Gelfand, John R. Pollard, R. Edward Hogan, G...> ;Neurology. 2019 Apr 9
132 citations
Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results
Jerzy P. Szaflarski, E. M. Bebin, Anne M. Comi, Anup D. Patel, Charuta Joshi, Daniel Checketts, Jules C. Beal, Linda Laux, Lisa M. De Boer, Matthew Wong, Merrick Lopez...> ;Epilepsia. 2018 Jul 12
107 citations
Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes.
Orrin Devinsky, Chloe Verducci, Elizabeth A. Thiele, Linda Laux, Anup D. Patel, Francis Filloux, Jerzy P. Szaflarski, Angus A. Wilfong, Gary D. Clark, Yong D. Park, La...> ;Epilepsy & Behavior. 2018 Sep 1
7 citations
Effects of adjunctive eslicarbazepine acetate on serum lipids in patients with partial-onset seizures: Impact of concomitant statins and enzyme-inducing antiepileptic ...
Scott Mintzer, Robert T. Wechsler, Joanne Rogin, Barry E. Gidal, Matthias Schwab, Elinor Ben-Menachem, Mar Carreño, Patricio Manuel Vieira Araujo Soares Da Silva, Joan...> ;Epilepsy Research. 2018 Mar 1
9 citations
Optimizing clobazam treatment in patients with Lennox-Gastaut syndrome.
Jouko Isojarvi, Barry E. Gidal, Steve Chung, Robert T. Wechsler> ;Epilepsy & Behavior. 2018 Jan 1
27 citations
Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension
Robert T. Wechsler, Stephen Yates, John Messenheimer, Robert Leroy, Cynthia Beller, Pamela Doty> ;Epilepsy Research. 2017 Feb 1
12 citations
Deconstructing tolerance with clobazam Post hoc analyses from an open-label extension study
Barry E. Gidal, Robert T. Wechsler, Raman Sankar, Georgia Montouris, H. Steve White, James C. Cloyd, Mary Clare Kane, Guangbin Peng, David M. Tworek, Vivienne Shen, Jo...> ;Neurology. 2016 Oct 25
14 citations
Long‐term exposure and safety of lacosamide monotherapy for the treatment of partial‐onset (focal) seizures: Results from a multicenter, open‐label trial
David G. Vossler, Robert T. Wechsler, Paulette Williams, William C. Byrnes, Sheila Therriault> ;Epilepsia. 2016 Oct 1
7 citations
Retinal structure and function in vigabatrin-treated adult patients with refractory complex partial seizures.
Robert C. Sergott, Chris A. Johnson, Kenneth D. Laxer, Robert T. Wechsler, Katya Cherny, JoAnn Whittle, Ge Feng, Deborah Lee, Jouko Isojarvi> ;Epilepsia. 2016 Sep 1
13 citations
Challenges in identifying Lennox-Gastaut syndrome in adults: A case series illustrating its changing nature
Jesus Eric Piña-Garza, Steve Chung, Georgia Montouris, Rodney A. Radtke, Trevor Resnick, Robert T. Wechsler> ;Epilepsy & Behavior Case Reports. 2016 Jan 1
Join now to see all

Lectures

The Northwest Regional Approach to Clinical Epilepsy
University of Washington School of Medicine, Seattle, Washington - 9/14/2013

Hospital Affiliations

St. Luke's Boise Medical CenterBoise, Idaho